Switchback Energy (NYSE:SBE) announced that its shareholders approved its combination with electric vehicle (EV) charging network ChargePoint at a special meeting earlier today.
The deal is now expected to close tomorrow, February 26. The combined entity’s shares and warrants are set to begin trading on the NYSE under the ticker symbols “CHPT” and “CHPT WS,” respectively, beginning March 1.
Switchback Energy did not detail redemption figures in its initial press release, but they are bound to have been limited given the company opened trading this morning ahead of the vote at $34.34.
The parties initially announced their $2.4 billion combination on September 24. Campbell, California-based ChargePoint has over 115,000 charging stations and its users have access to an additional 133,000 “roaming” locations across North American and Europe.
The deal has been among the most consistently appreciated EV SPAC combinations and has traded above $29 since late November.
ADVISORS
- BofA Securities is serving as exclusive financial advisor to ChargePoint.
- Oppenheimer & Co. Inc. is serving as capital markets advisor to ChargePoint.
- Weil, Gotshal & Manges LLP and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP are serving as legal advisors to ChargePoint.
- Goldman Sachs & Co. LLC is serving as exclusive financial advisor to Switchback.
- Vinson & Elkins L.L.P. is serving as legal advisor to Switchback.
- Goldman Sachs & Co. LLC is serving as lead placement agent with BofA Securities and Oppenheimer & Co. Inc. serving as co-placement agents on the PIPE.
- Financial Profiles, Inc. is serving as investor relations advisor for ChargePoint.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...